292 related articles for article (PubMed ID: 28246388)
1. Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes.
de Gonzalo-Calvo D; van der Meer RW; Rijzewijk LJ; Smit JW; Revuelta-Lopez E; Nasarre L; Escola-Gil JC; Lamb HJ; Llorente-Cortes V
Sci Rep; 2017 Mar; 7(1):47. PubMed ID: 28246388
[TBL] [Abstract][Full Text] [Related]
2. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage.
Kuwabara Y; Ono K; Horie T; Nishi H; Nagao K; Kinoshita M; Watanabe S; Baba O; Kojima Y; Shizuta S; Imai M; Tamura T; Kita T; Kimura T
Circ Cardiovasc Genet; 2011 Aug; 4(4):446-54. PubMed ID: 21642241
[TBL] [Abstract][Full Text] [Related]
3. Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy.
Copier CU; León L; Fernández M; Contador D; Calligaris SD
Sci Rep; 2017 Oct; 7(1):13514. PubMed ID: 29044172
[TBL] [Abstract][Full Text] [Related]
4. Value of circulating miRNA-21 in the diagnosis of subclinical diabetic cardiomyopathy.
Tao L; Huang X; Xu M; Qin Z; Zhang F; Hua F; Jiang X; Wang Y
Mol Cell Endocrinol; 2020 Dec; 518():110944. PubMed ID: 32717421
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes.
Rodríguez-Calvo R; Girona J; Rodríguez M; Samino S; Barroso E; de Gonzalo-Calvo D; Guaita-Esteruelas S; Heras M; van der Meer RW; Lamb HJ; Yanes O; Correig X; Llorente-Cortés V; Vázquez-Carrera M; Masana L
Metabolism; 2019 Jul; 96():12-21. PubMed ID: 30999003
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway.
Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K
Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209
[TBL] [Abstract][Full Text] [Related]
8. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1.
Yildirim SS; Akman D; Catalucci D; Turan B
Cell Biochem Biophys; 2013; 67(3):1397-408. PubMed ID: 23723006
[TBL] [Abstract][Full Text] [Related]
9. High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patients.
Escate R; Padró T; Suades R; Camino S; Muñiz O; Diaz-Diaz JL; Sionis A; Mata P; Badimon L
Cardiovasc Res; 2021 Jan; 117(1):109-122. PubMed ID: 32061123
[TBL] [Abstract][Full Text] [Related]
10. Correlation between miR-103 and miR-133a Expression and the Circulating ANGPTL8 in Type 2 Diabetic Patients and Healthy Control Subjects.
Ghasemi H; Karimi J; Khodadadi I; Tavilani H
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710446
[TBL] [Abstract][Full Text] [Related]
11. The relationship between myocardial fibrosis and myocardial microRNAs in dilated cardiomyopathy: A link between mir-133a and cardiovascular events.
Rubiś P; Totoń-Żurańska J; Wiśniowska-Śmiałek S; Dziewięcka E; Kołton-Wróż M; Wołkow P; Pitera E; Rudnicka-Sosin L; Garlitski AC; Gackowski A; Podolec P
J Cell Mol Med; 2018 Apr; 22(4):2514-2517. PubMed ID: 29377565
[TBL] [Abstract][Full Text] [Related]
12. Combined Use of Circulating miR-133a and NT-proBNP Improves Heart Failure Diagnostic Accuracy in Elderly Patients.
Guo M; Luo J; Zhao J; Shang D; Lv Q; Zang P
Med Sci Monit; 2018 Dec; 24():8840-8848. PubMed ID: 30523241
[TBL] [Abstract][Full Text] [Related]
13. Levels of circulating miR-133a are elevated in sepsis and predict mortality in critically ill patients.
Tacke F; Roderburg C; Benz F; Cardenas DV; Luedde M; Hippe HJ; Frey N; Vucur M; Gautheron J; Koch A; Trautwein C; Luedde T
Crit Care Med; 2014 May; 42(5):1096-104. PubMed ID: 24413579
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and Prognostic Value of Circulating MicroRNA-133a in Patients with Acute Myocardial Infarction.
Yuan L; Liu X; Chen F; Zhang L; Chen X; Huang Q; Wu D; Yang C; Han Z
Clin Lab; 2016 Jul; 62(7):1233-1241. PubMed ID: 28164636
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of microRNA-133a inhibits ischemia-reperfusion-induced cardiomyocyte apoptosis by targeting DAPK2.
Li S; Xiao FY; Shan PR; Su L; Chen DL; Ding JY; Wang ZQ
J Hum Genet; 2015 Nov; 60(11):709-16. PubMed ID: 26334104
[TBL] [Abstract][Full Text] [Related]
16. Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes.
Wolf P; Winhofer Y; Krssak M; Smajis S; Harreiter J; Kosi-Trebotic L; Fürnsinn C; Anderwald CH; Baumgartner-Parzer S; Trattnig S; Luger A; Krebs M
Nutr Metab Cardiovasc Dis; 2016 May; 26(5):387-92. PubMed ID: 27118107
[TBL] [Abstract][Full Text] [Related]
17. Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy.
Liebetrau C; Möllmann H; Dörr O; Szardien S; Troidl C; Willmer M; Voss S; Gaede L; Rixe J; Rolf A; Hamm C; Nef H
J Am Coll Cardiol; 2013 Sep; 62(11):992-8. PubMed ID: 23747779
[TBL] [Abstract][Full Text] [Related]
18. Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction.
Bauters C; Kumarswamy R; Holzmann A; Bretthauer J; Anker SD; Pinet F; Thum T
Int J Cardiol; 2013 Oct; 168(3):1837-40. PubMed ID: 23347612
[TBL] [Abstract][Full Text] [Related]
19. Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples.
Gidlöf O; Andersson P; van der Pals J; Götberg M; Erlinge D
Cardiology; 2011; 118(4):217-26. PubMed ID: 21701171
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart.
Costantino S; Paneni F; Lüscher TF; Cosentino F
Eur Heart J; 2016 Feb; 37(6):572-6. PubMed ID: 26553540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
